Both in Biotechnology
aTyr Pharma vs Scilex Holding
Over the past year ATYR returned −61.3% and SCLX returned −83.4%; their daily moves had a correlation of 0.11.
ATYR −61.3% SCLX −83.4%Growth of $1, one year, split-adjusted
| Metric | ATYR | SCLX |
|---|---|---|
| Price | $0.3077 | $4.41 |
| Market cap | $30.2M | $31.0M |
| Today | +3.36% | −1.78% |
| 1 month | −43.0% | −18.8% |
| 6 months | −57.9% | −30.3% |
| Year to date | −60.7% | −63.9% |
| 1 year | −63.4% | −84.9% |
| Revenue growth (YoY) | — | −22.8% |
| Gross margin | — | 51.9% |
| Net margin | — | −1501.3% |
| P/E (TTM) | — | — |
| Price / sales | 158.9× | 1.0× |
| Net cash | $56.9M | -$82.5M |
| Dividend yield | — | — |
| Volatility (60d) | 75.1% | 77.3% |
| Short % of float | 10.9% | 2.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).